Australia's largest stock trading and investment forum Australia's #1 stock forum

PCK

3.23%

3.0¢ painchek ltd

Media Thread, page-961

First 961 Last

Share
Profile

Follow
AlCp

27,387 Posts.

1778

25/03/23

00:31

Post #: 66953278
Share

Originally posted by Salubrious ↑

While it is true that the uptake of Painchek technology may not be as widespread globally as it could be, it's important to note that the company is still relatively new and making strides in expanding its reach. Additionally, the stalled uptake in some areas may be due to a variety of factors, including market conditions and competition, rather than a reflection of the technology's effectiveness.
It's also worth noting that the share price of a company is affected by a range of factors, including market sentiment, investor confidence, and company performance, and cannot be solely attributed to the uptake of a particular technology.
Overall, Painchek technology has shown promise in improving patient care and streamlining assessment processes, and the company continues to work towards expanding its reach and improving uptake.

Expand

The uptake here has also stalled after the government grant...... The biggest competitor has always been the APS process itself so eliminating the need to do 5 out of 6 manual process will make a massive point of difference for the technology

PCK Price at posting: 3.0¢ Sentiment: None Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

BUX

Buxton projects new graphite province discovery at WA Narryer play

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

There are more pages in this discussion • 832 more messages in this thread...

First 961 Last

Add PCK (ASX) to my watchlist

(20min delay)
Last 3.0¢		Change -0.001(3.23%)		Mkt cap ! $49.11M

Open	High	Low	Value	Volume
3.0¢	3.0¢	3.0¢	$12.08K	402.6K

Buyers (Bids)

No.	Vol.	Price($)
8	305189	3.0¢

Sellers (Offers)

Price($)	Vol.	No.
3.1¢	99999	1

View Market Depth

No.	Vol.	Price($)
8	305189	0.030
5	6607448	0.029
1	350000	0.028
3	488344	0.027
4	1600000	0.026

Price($)	Vol.	No.
0.031	99999	1
0.032	102605	2
0.033	126161	2
0.034	79638	2
0.035	125000	1

Last trade - 16.10pm 04/10/2024 (20 minute delay)

PCK (ASX) Chart

Media Thread, page-961

BCI reaches close of funding facility for salt-first part of Mardie project

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Media Thread, page-961

Top Stories

BCI reaches close of funding facility for salt-first part of Mardie project

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News